Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Reply to 'Strengths and limitations of estimated and measured GFR'.

Porrini E, Ruggenenti P, Luis-Lima S, Carrara F, Jiménez A, de Vries APJ, Torres A, Gaspari F, Remuzzi G.

Nat Rev Nephrol. 2019 Dec;15(12):785-786. doi: 10.1038/s41581-019-0214-8. No abstract available.

PMID:
31578496
2.

Response to "Iohexol-measured glomerular filtration rate in children and adolescents with chronic kidney disease: a pilot study comparing venous and finger stick methods".

Lima SL, Gaspari F, Carrara F, Porrini E.

Pediatr Nephrol. 2019 Sep;34(9):1629-1630. doi: 10.1007/s00467-019-04285-9. Epub 2019 Jun 16. No abstract available.

PMID:
31203493
3.

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial.

Perico N, Ruggenenti P, Perna A, Caroli A, Trillini M, Sironi S, Pisani A, Riccio E, Imbriaco M, Dugo M, Morana G, Granata A, Figuera M, Gaspari F, Carrara F, Rubis N, Villa A, Gamba S, Prandini S, Cortinovis M, Remuzzi A, Remuzzi G; ALADIN 2 Study Group.

PLoS Med. 2019 Apr 5;16(4):e1002777. doi: 10.1371/journal.pmed.1002777. eCollection 2019 Apr.

4.

Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial.

Ruggenenti P, Trillini M, P Barlovic D, Cortinovis M, Pisani A, Parvanova A, Iliev IP, Ruggiero B, Rota S, Aparicio MC, Perna A, Peraro F, Diadei O, Gaspari F, Carrara F, Stucchi N, Martinetti D, Janez A, Gregoric N, Riccio E, Bossi AC, Trevisan R, Manunta P, Battaglia G, David S, Aucella F, Belviso A, Satta A, Remuzzi G; VALID Study Organization.

Diabetes Obes Metab. 2019 May;21(5):1177-1190. doi: 10.1111/dom.13639. Epub 2019 Feb 22.

PMID:
30793466
5.

Author Correction: Estimated GFR: time for a critical appraisal.

Porrini E, Ruggenenti P, Luis-Lima S, Carrara F, Jiménez A, de Vries APJ, Torres A, Gaspari F, Remuzzi G.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0105-4.

PMID:
30563967
6.

Estimated GFR: time for a critical appraisal.

Porrini E, Ruggenenti P, Luis-Lima S, Carrara F, Jiménez A, de Vries APJ, Torres A, Gaspari F, Remuzzi G.

Nat Rev Nephrol. 2019 Mar;15(3):177-190. doi: 10.1038/s41581-018-0080-9. Review. Erratum in: Nat Rev Nephrol. 2018 Dec 18;:.

PMID:
30518813
7.

Safety of Iohexol Administration to Measure Glomerular Filtration Rate in Different Patient Populations: A 25-Year Experience.

Gaspari F, Thakar S, Carrara F, Perna A, Trillini M, Aparicio MC, Diadei O, Ferrari S, Cannata A, Stucchi N, Ruggenenti P, Remuzzi G, Perico N.

Nephron. 2018;140(1):1-8. doi: 10.1159/000489898. Epub 2018 May 17.

PMID:
29772565
8.

A Simple Method to Measure Renal Function in Swine by the Plasma Clearance of Iohexol.

Luis-Lima S, García-Contreras C, Vázquez-Gómez M, Astiz S, Carrara F, Gaspari F, Negrín-Mena N, Jiménez-Sosa A, Jiménez-Hernández H, González-Bulnes A, Porrini E.

Int J Mol Sci. 2018 Jan 12;19(1). pii: E232. doi: 10.3390/ijms19010232.

9.

Iohexol plasma clearance simplified by dried blood spot testing.

Luis-Lima S, Gaspari F, Negrín-Mena N, Carrara F, Díaz-Martín L, Jiménez-Sosa A, González-Rinne F, Torres A, Porrini E.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1597-1603. doi: 10.1093/ndt/gfx323.

PMID:
29211858
10.

Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.

Parvanova A, Trillini M, Podestà MA, Iliev IP, Ruggiero B, Abbate M, Perna A, Peraro F, Diadei O, Rubis N, Gaspari F, Carrara F, Stucchi N, Belviso A, Bossi AC, Trevisan R, Remuzzi G, de Borst M, Ruggenenti P; PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016.

Lancet Diabetes Endocrinol. 2018 Jan;6(1):27-40. doi: 10.1016/S2213-8587(17)30359-5. Epub 2017 Nov 2.

PMID:
29104158
11.

Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients.

Cortinovis M, Gotti E, Trillini M, Carrara F, Gaspari F, Ruggenenti P, Remuzzi G, Perico N.

Nephron. 2017;135(3):173-180. doi: 10.1159/000453671. Epub 2016 Dec 10.

PMID:
27941326
12.

Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled Trial.

Ruggenenti P, Abbate M, Ruggiero B, Rota S, Trillini M, Aparicio C, Parvanova A, Petrov Iliev I, Pisanu G, Perna A, Russo A, Diadei O, Martinetti D, Cannata A, Carrara F, Ferrari S, Stucchi N, Remuzzi G, Fontana L; C.RE.S.O. Study Group.

Diabetes. 2017 Jan;66(1):75-86. doi: 10.2337/db16-0607. Epub 2016 Sep 15.

13.

Iohexol plasma clearance, a simple and reliable method to measure renal function in conscious mice.

Luis-Lima S, Rodríguez-Rodríguez AE, Martín-Higueras C, Sierra-Ramos C, Carrara F, Arnau MR, Alvarez de la Rosa D, Salido E, Gaspari F, Porrini E.

Pflugers Arch. 2016 Sep;468(9):1587-94. doi: 10.1007/s00424-016-1843-4. Epub 2016 Jun 17.

PMID:
27315812
14.

Simplified Method to Measure Glomerular Filtration Rate by Iohexol Plasma Clearance in Conscious Rats.

Carrara F, Azzollini N, Nattino G, Corna D, Villa S, Cerullo D, Zoja C, Abrante B, Luis-Lima S, Porrini E, Cannata A, Ferrari S, Fois M, Stucchi N, Gaspari F.

Nephron. 2016;133(1):62-70. doi: 10.1159/000445843. Epub 2016 May 4.

PMID:
27160992
15.

Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.

Ruggenenti P, Gentile G, Perico N, Perna A, Barcella L, Trillini M, Cortinovis M, Ferrer Siles CP, Reyes Loaeza JA, Aparicio MC, Fasolini G, Gaspari F, Martinetti D, Carrara F, Rubis N, Prandini S, Caroli A, Sharma K, Antiga L, Remuzzi A, Remuzzi G; SIRENA 2 Study Group.

Clin J Am Soc Nephrol. 2016 May 6;11(5):785-94. doi: 10.2215/CJN.09900915. Epub 2016 Feb 22.

16.

Estimated Glomerular Filtration Rate in Renal Transplantation: The Nephrologist in the Mist.

Luis-Lima S, Marrero-Miranda D, González-Rinne A, Torres A, González-Posada JM, Rodríguez A, Salido E, Aldea-Perona A, Gaspari F, Carrara F, Gómez-Gerique JA, Negrín-Mena N, Pérez-Tamajón L, González-Rinne F, Jiménez-Hernández H, Jiménez-Sosa A, Porrini E.

Transplantation. 2015 Dec;99(12):2625-33. doi: 10.1097/TP.0000000000000786.

PMID:
26247554
17.

Determination of iohexol in human serum by a semi-automated liquid chromatography tandem mass spectrometry method.

Vicente FB, Vespa GK, Carrara F, Gaspari F, Haymond S.

Clin Biochem. 2015 Jul;48(10-11):679-85. doi: 10.1016/j.clinbiochem.2015.03.017. Epub 2015 Mar 31.

PMID:
25835151
18.

Measurement of glomerular filtration rate: internal and external validations of the iohexol plasma clearance technique by HPLC.

Luis-Lima S, Gaspari F, Porrini E, García-González M, Batista N, Bosa-Ojeda F, Oramas J, Carrara F, González-Posada JM, Marrero D, Salido E, Torres A, Jiménez-Sosa A.

Clin Chim Acta. 2014 Mar 20;430:84-5. doi: 10.1016/j.cca.2013.12.028. Epub 2014 Jan 2. No abstract available.

PMID:
24389053
19.

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.

Caroli A, Perico N, Perna A, Antiga L, Brambilla P, Pisani A, Visciano B, Imbriaco M, Messa P, Cerutti R, Dugo M, Cancian L, Buongiorno E, De Pascalis A, Gaspari F, Carrara F, Rubis N, Prandini S, Remuzzi A, Remuzzi G, Ruggenenti P; ALADIN study group.

Lancet. 2013 Nov 2;382(9903):1485-95. doi: 10.1016/S0140-6736(13)61407-5. Epub 2013 Aug 21.

PMID:
23972263
20.

The GFR and GFR decline cannot be accurately estimated in type 2 diabetics.

Gaspari F, Ruggenenti P, Porrini E, Motterlini N, Cannata A, Carrara F, Jiménez Sosa A, Cella C, Ferrari S, Stucchi N, Parvanova A, Iliev I, Trevisan R, Bossi A, Zaletel J, Remuzzi G; GFR Study Investigators.

Kidney Int. 2013 Jul;84(1):164-73. doi: 10.1038/ki.2013.47. Epub 2013 Feb 27.

Supplemental Content

Loading ...
Support Center